ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Taysha Gene Therapies, INC.

Official 2024 U.S. DOL Form 5500 summary for Taysha Gene Therapies, INC. (Taysha Gene Therapies 401(k) Plan · EIN 84-3199512 · PN 001): $6.17M net assets, 73 active participants, and Sponsor-paid or unbenchmarked.

Reported Form 5500 Fee & Service Summary

Plan SponsorTaysha Gene Therapies, INC.
Filing IdentifierTaysha Gene Therapies 401(k) Plan · EIN 84-3199512 · PN 001
Plan Category & State401(k) Defined Contribution (TX)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$6.17M
Active Participants73
Direct Admin Fee RateSponsor-paid or unbenchmarked
Cohort Peer MedianN/A
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI